Factor V Leiden and recurrent miscarriage

Michael K. Bohlmann, Michael von Wolff and Thomas Strowitzki

Department of Gynecologic Endocrinology and Reproductive Medicine, Women's Hospital, University Hospital Heidelberg, Voss-Str. 9, 69115 Heidelberg, Germany E-mail: michael.bohlmann{at}med.uni-heidelberg.de


    Introduction
 Top
 Introduction
 References
 
Dear Sir,

We read with interest the article by Rai and colleagues concerning the prospective outcome of untreated pregnancies in patients with factor V Leiden mutation and recurrent miscarriages (Rai et al., 2002Go). Rai and colleagues should be congratulated for their skilful evaluation of their data, showing a significantly lower live birth rate amongst women carrying the factor V allele (37.5%) compared with those of a normal genotype (69.3%).

However, a few questions have to be put forward. As the authors state that the women in the control group, `Did not receive pharmacological treatment except for folic acid' during pregnancy, it would have been of interest to know what the underlying pathologies (if any) had been causing more than two recurrent miscarriages before this observed pregnancy. Otherwise these patients have to be considered as idiopathic recurrent aborters.

Some authors have linked endocrine disorders such as hyperprolactinaemia (Hirahara et al., 1998Go), hypothyroidism (Abalovich et al., 2002Go) and a status of hyperandrogenaemia (Bussen et al., 1999Go) to pregnancy complications or recurrent miscarriages. It would have been of interest if there were any significant differences with regard to these pathologies between both groups of patients.

Furthermore, it remains to be elucidated if any other thrombophilic changes, also carrying a risk for abortions, such as decreased factor XII activity (Braulke et al., 1993Go; Ogasawara et al., 2001Go; Iinuma et al., 2002Go) or hyperhomocysteinaemia (Nelen et al., 2000Go) have been detected in patients of either group. The prevalence of combined thrombophilic defects (Sarig et al., 2002Go) would be of interest in the group of patients who carry the factor V Leiden allele. Since, for example, Martinelli et al. described an increased risk for thrombosis in pregnant patients with double heterozygous factor V and prothrombin gene mutations (Martinelli et al., 2001Go), one might assume that such a double mutation might also have an impact on the occurrence of placental malperfusion.

In addition, the numbers in the Abstract do not match: early miscarriage: n = 19, late miscarriage: n = 9, total number 28, compared with 25 as stated by the authors.


    References
 Top
 Introduction
 References
 
Abalovich, M., Gutierrez, S., Alcaraz, G., Maccallini, G., Garcia, A. and Levalle, O. (2002) Overt and subclinical hypothyroidism complicating pregnancy. Thyroid, 12, 63–68.[ISI][Medline]

Braulke, I., Pruggmayer, M., Melloh, P., Hinney, B., Kostering, H. and Gunther, E. (1993) Factor XII (Hageman) deficiency in women with habitual abortion: new subpopulation of recurrent aborters? Fertil. Steril., 59, 98–101.[ISI][Medline]

Bussen, S., Sutterlin, M. and Steck, T. (1999) Endocrine abnormalities during the follicular phase in women with recurrent spontaneous abortion. Hum. Reprod., 14, 18–20.[Abstract/Free Full Text]

Hirahara, F., Andoh, N., Sawai, K., Hirabuki, T., Uemura , T. and Minaguchi, H. (1998) Hyperprolactinemic recurrent miscarriage and results of randomized bromocriptine treatment trials. Fertil. Steril., 70, 246–252.[ISI][Medline]

Iinuma, Y., Sugiura-Ogasawara, M., Makino, A., Ozaki, Y., Suzumori, N. and Suzumori, K. (2002) Coagulation factor XII activity, but not an associated common genetic polymorphism (46C/T), is linked to recurrent miscarriage. Fertil. Steril., 77, 353–356.[ISI][Medline]

Martinelli, I., Legnani, C., Bucciarelli, P., Grandone, E., de Stefano, V. and Mannucci, P.M. (2001) Risk of pregnancy-related venous thrombosis in carriers of severe inherited thrombophilia. Thromb. Haemost., 86, 800–803.[ISI][Medline]

Nelen, W.L., Blom, H.J., Steegers, E.A., den Heijer, M. and Eskes, T.K. (2000) Hyperhomocysteinemia and recurrent early pregnancy loss: a meta-analysis. Fertil. Steril., 74, 1196–1199.[ISI][Medline]

Ogasawara, M.S., Aoki, K., Katano, K., Ozaki, Y. and Suzumori, K. (2001) Factor XII but not protein C, protein S, antithrombin III, or factor XIII is a predictor of recurrent miscarriage. Fertil. Steril., 75, 916–919.[ISI][Medline]

Rai, R., Backos, M., Elgaddal, S., Shlebak, A. and Regan, L. (2002) Factor V Leiden and recurrent miscarriage-prospective outcome of untreated pregnancies. Hum. Reprod., 17, 442–445.[Abstract/Free Full Text]

Sarig, G., Younis, J.S., Hoffman, R. Ianir, N., Blumenfeld, Z. and Brenner, B. (2002) Thrombophilia is common in women with idiopathic pregnancy loss and is associated with late pregnancy wastage. Fertil. Steril., 77, 342–347.[ISI][Medline]





This Article
Extract
FREE Full Text (PDF )
Alert me when this article is cited
Alert me if a correction is posted
Services
Email this article to a friend
Similar articles in this journal
Similar articles in ISI Web of Science
Similar articles in PubMed
Alert me to new issues of the journal
Add to My Personal Archive
Download to citation manager
Request Permissions
Google Scholar
Articles by Bohlmann, M. K.
Articles by Strowitzki, T.
PubMed
PubMed Citation
Articles by Bohlmann, M. K.
Articles by Strowitzki, T.